Deep inside the bony tunnel of a dog’s pelvis, a slow-growing mass of fat can quietly squeeze the colon, the bladder, and the nerves that keep the hindquarters working. Because the pelvic canal is packed with critical structures—the distal colon, rectum, vagina, prostate, sacral lymph nodes, neural tissue, and peripelvic blood vessels—any tumor that takes up residence there tends to announce itself through problems with defecation or urination, and sometimes through signs that become life-threatening. A new multi-institutional study published in Veterinary Oncology has now assembled the largest picture to date of one of the rarest residents of this anatomical neighborhood: the intrapelvic lipoma, a benign tumor of adipose tissue that most veterinarians might never expect to encounter in a lifetime of practice.
The research, led by Marianne Lappalainen of the Royal Veterinary College in London together with colleagues from referral centers across the United Kingdom, France, Belgium, Ireland, Switzerland, Spain, and Italy, took a retrospective approach. The team contacted veterinary oncology services across Europe and combed their medical records for dogs in which advanced imaging reviewed by a board-certified radiologist had been combined with cytological or histological confirmation of a primary intrapelvic lipoma. Crucially, the investigators excluded any mass that had merely spread into the pelvis from elsewhere, ensuring that every case represented a tumor that truly originated within the pelvic canal. Because the condition is so rare, the authors set no time limit on case selection, gathering examples across an open-ended window. Thirteen dogs made the final cut.
The affected dogs were, in keeping with what is known about lipomas in general, middle-aged to older animals. The median age at diagnosis was nine years and five months, with a range from roughly seven and a half to twelve years, and the median body weight was 24.45 kilograms. English Springer Spaniels topped the breed list with three of the thirteen cases, followed by crossbreeds and Labrador crosses; single cases appeared in Labrador Retrievers, Standard Poodles, English Cocker Spaniels, West Highland White Terriers, Golden Retrievers, and Smooth Collies. Interestingly, males slightly outnumbered females in this cohort, with a male-to-female ratio of four to three—a finding that runs counter to earlier UK primary-care studies suggesting that neutered females carry a higher risk of lipomas overall. The authors caution that the small sample size may explain the discrepancy.
The clinical picture was dominated by the bowel. Tenesmus—persistent, straining attempts to defecate—was recorded in nine of the thirteen dogs, or 69.2 percent. Altered stool shape, the classic signature of a mass compressing the colon and rectum into a narrowed channel, appeared in six dogs (46.15 percent), while dyschezia, painful or difficult defecation, affected four dogs (30.7 percent). Two dogs struggled to urinate, and one presented with constipation and vomiting. Remarkably, one lipoma was discovered incidentally during a routine rectal examination in a dog whose owners had noticed nothing wrong. For the rest, clinical signs had been present for a median of just twenty-one days before diagnosis, ranging from five to 180 days—a shorter interval than the seven and a half months reported in earlier work on benign and low-grade intrapelvic tumors, though individual dogs in this series did endure signs for up to six months.
Computed tomography emerged as the undisputed diagnostic hero of the study. Every dog underwent a CT scan, and in twelve of the thirteen cases (92.3 percent) the mass displayed the hallmark fat attenuation that essentially announces a lipoma on the scan. The thirteenth dog’s mass showed a mixture of fat and soft-tissue attenuation, yet histopathology subsequently confirmed it as adipose tissue all the same. In one case the CT report described the mass as infiltrative, a detail that would later prove prognostically important. On cross-sectional images, the tumors showed a striking positional preference: of the ten dogs in which the location was described, nine had lipomas on the left side of the pelvic canal, shoving the colon and rectum to the right. Where measurements permitted, the team calculated tumor volumes using the ellipsoid formula, finding a median volume of 161.2 cubic centimeters and dimensions ranging from about 5 by 3 by 5 centimeters in a Springer Spaniel to a remarkable 6 by 3 by 23 centimeters in a Labrador Retriever.
The imaging modality matters because the pelvic bones themselves conspire against simpler tools. Abdominal radiography and ultrasonography, the workhorses of general practice, struggle to visualize masses in this region because the surrounding bone obscures detail. Ultrasound can suggest a lipoma when it reveals an oval, well-defined, encapsulated mass with internal striations, hyperechogenicity, and a telltale absence of blood flow on color Doppler examination, while liposarcomas tend to appear heterogeneous with increased vascularity and invasion of nearby structures. But CT provides something neither can: precise information about a mass’s size, extent, and relationship to surrounding organs, which is indispensable for surgical planning. In human medicine, magnetic resonance imaging is often preferred for its superior soft-tissue contrast, but in veterinary oncology MRI remains rarely used for staging or surgical planning due to time and cost. The study’s findings suggest that for these patients, a CT scan alone can deliver a confident radiological diagnosis, potentially eliminating the need for preoperative cytohistopathology in some cases.
All thirteen dogs underwent surgery, via either a perineal approach in two cases or a caudal ventral celiotomy in seven; the surgical reports for four dogs were unavailable for review. No intraoperative complications were reported anywhere in the cohort, and the only perioperative problem was a single wound dehiscence two days after surgery, which was repaired without further incident. Pathology confirmed the benign nature of the tumors: all initial histopathology reports described well-differentiated adipocytes, the microscopic signature of a lipoma. Yet the very blandness of these tumors creates a diagnostic trap, because lipomas histologically resemble normal subcutaneous fat and often lack clear borders, making surgical margins difficult or impossible to evaluate. Margins went unreported in twelve of the dogs, a gap the authors attribute to the difficulty of distinguishing neoplastic from normal adipocytes, the benign expansile nature of the growths, or inadequate sampling.
The outcomes were largely encouraging, with one sobering caveat. Four dogs remain alive with a median follow-up of 507 days after diagnosis. Five dogs were euthanized, but only one of those deaths was attributed to the lipoma itself; the median time to death among the four with known dates was 889 days, ranging up to 1,740 days. Kaplan–Meier analysis, which accounts for the heavily censored data produced by long survival and lost follow-up, yielded an overall survival time of 1,020 days—nearly three years. The caveat concerns recurrence: three dogs (23.1 percent) experienced regrowth at a median of 220 days after their initial surgeries, a rate the authors note is uncomfortably close to figures reported for infiltrative lipomas, a more aggressive variant whose recurrence rates after excision range from 36 to 50 percent even with aggressive surgery. One recurrent case was confirmed histologically as an infiltrative lipoma, matching the earlier CT suspicion of infiltration.
Even more striking was the fate of one dog that recurred twice. Cytology at its third relapse suggested malignant transformation into a soft tissue sarcoma, and the dog was switched to metronomic chemotherapy—oral low-dose cyclophosphamide combined with the anti-inflammatory drug meloxicam. The authors weigh several explanations: an initial misdiagnosis, an original mixed tumor only partially characterized, or the development of sarcoma following repeated surgical injury, a phenomenon with tentative support in the literature linking tissue trauma to sarcoma formation. A fourth dog suspected of recurrence turned out to have intra-abdominal adhesions rather than tumor, though without necropsy the team could not definitively rule out regrowth. The episode underscores a broader point: not every returning symptom means the cancer is back.
For veterinary clinicians, the practical takeaways are concrete. A lipoma belongs on the differential diagnosis list for any intrapelvic mass in a dog, and CT imaging can reliably identify its fat content and map its relationship to the colon, rectum, and urinary tract. Surgical excision, though demanding specialized expertise that may exceed the capabilities of general practice, offers a favorable prognosis with low complication rates and survival approaching three years—provided owners and veterinarians remain vigilant for recurrence, particularly when the initial imaging hints at infiltrative behavior. The authors acknowledge the limits of their work: a small sample, retrospective design, referral-only population, and loss of follow-up in nearly a third of cases all constrain the statistics. Larger studies with longer follow-up, including cases of infiltrative lipoma, will be needed to refine the prognosis and clarify how different treatments shape outcomes. Until then, this rare and easily overlooked tumor has a documented playbook—and for most dogs, a genuinely good ending.
Subject of Research: Clinical presentation, CT diagnosis, surgical treatment, and outcomes of intrapelvic lipomas in dogs
Article Title: Presentation, treatment, and outcome of lipomas of the pelvic canal in dogs
Article References: Lappalainen, M., Gomez Fernandez, J., Béguin, J., Fournier, Q., Hayes, A., Bing, Y., Rodiño-Tilve, V., Bazelle, J., Borrego, J., & Desmas-Bazelle, I. (2025). Presentation, treatment, and outcome of lipomas of the pelvic canal in dogs. Veterinary Oncology, 2(1), Article 28. https://doi.org/10.1186/s44356-025-00044-1
Image Credits: AI Generated
DOI: 10.1186/s44356-025-00044-1
Keywords: lipoma, dogs, pelvic canal, computed tomography, veterinary oncology, surgical excision, tenesmus, dyschezia, infiltrative lipoma, recurrence, Kaplan-Meier survival, case series
Cite Scienmag News
APA
MLA
Chicago
Nathaniel Bowman. (October 1, 2026). Hidden Fat Tumors in Dogs’ Pelvises Turn Out More Treatable Than Feared. Scienmag. https://scienmag.com/hidden-fat-tumors-in-dogs-pelvises-turn-out-more-treatable-than-feared/
Nathaniel Bowman. “Hidden Fat Tumors in Dogs’ Pelvises Turn Out More Treatable Than Feared.” Scienmag, 1 October 2026, https://scienmag.com/hidden-fat-tumors-in-dogs-pelvises-turn-out-more-treatable-than-feared/. Accessed 1 October 2026.
Nathaniel Bowman. “Hidden Fat Tumors in Dogs’ Pelvises Turn Out More Treatable Than Feared.” Scienmag. October 1, 2026. https://scienmag.com/hidden-fat-tumors-in-dogs-pelvises-turn-out-more-treatable-than-feared/
Copy citation
Download RIS
Tags: benign fat tumors in canine pelviscanine pelvic tumor diagnosiscase seriescomputed tomographydifferentiation of benign and malignant pelvic tumorsdog pelvic tumorsdogsdyscheziaimaging of dog pelvic tumorsinfiltrative lipomaintrapelvic lipoma in dogsKaplan-Meier survivallipomamulti-institutional veterinary researchpelvic canalprognosis of pelvic fat tumors in dogsrecurrencesigns of pelvic tumors in dogssurgical excisionsurgical removal of pelvic lipomastenesmustreatment of intrapelvic lipomasveterinary oncologyveterinary oncology pelvic masses
